Drug profile · INN
artemether + lumefantrine
RIAMET
artemether + lumefantrine (RIAMET) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
TGA: approved
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — artemether + lumefantrine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.81
Quick answer
artemether + lumefantrine (RIAMET) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is artemether + lumefantrine?
artemether + lumefantrine (RIAMET) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
What is the brand name for artemether + lumefantrine?
RIAMET is a marketed brand name for artemether + lumefantrine. Check FDA Drugs@FDA for the current US label holder and prescribing information.